Arterra Bioscience S.p.A.

BIT:ARBS Stock Report

Market Cap: €20.2m

Arterra Bioscience Management

Management criteria checks 2/4

Arterra Bioscience's CEO is Maria Colucci, appointed in Jan 2022, has a tenure of 4.67 years. directly owns 20.89% of the company’s shares, worth €4.23M. The average tenure of the management team and the board of directors is 4.7 years and 4.7 years respectively.

Key information

Maria Colucci

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.7yrs
CEO ownership20.9%
Management average tenure4.7yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Analysis Article • May 10

Arterra Bioscience's (BIT:ARBS) Promising Earnings May Rest On Soft Foundations

Investors were disappointed with Arterra Bioscience S.p.A.'s ( BIT:ARBS ) earnings, despite the strong profit numbers...
Analysis Article • Mar 28

Here's Why We Think Arterra Bioscience (BIT:ARBS) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article • Apr 15

Arterra Bioscience's (BIT:ARBS) Dividend Will Be Increased To €0.13

The board of Arterra Bioscience S.p.A. ( BIT:ARBS ) has announced that it will be paying its dividend of €0.13 on the...
Analysis Article • Apr 01

Arterra Bioscience (BIT:ARBS) Is Paying Out A Larger Dividend Than Last Year

The board of Arterra Bioscience S.p.A. ( BIT:ARBS ) has announced that it will be increasing its dividend by 30% on the...
Analysis Article • Feb 13

Arterra Bioscience S.p.A.'s (BIT:ARBS) P/E Is On The Mark

There wouldn't be many who think Arterra Bioscience S.p.A.'s ( BIT:ARBS ) price-to-earnings (or "P/E") ratio of 12.6x...
Analysis Article • Aug 03

A Look At The Fair Value Of Arterra Bioscience S.p.A. (BIT:ARBS)

Key Insights The projected fair value for Arterra Bioscience is €1.90 based on 2 Stage Free Cash Flow to Equity Arterra...
Analysis Article • Jan 09

A Look At The Fair Value Of Arterra Bioscience S.p.A. (BIT:ABS)

Key Insights Arterra Bioscience's estimated fair value is €2.3 based on 2 Stage Free Cash Flow to Equity Current share...
Analysis Article • May 27

Estimating The Intrinsic Value Of Arterra Bioscience S.p.A. (BIT:ABS)

Today we will run through one way of estimating the intrinsic value of Arterra Bioscience S.p.A. ( BIT:ABS ) by taking...

CEO

Maria Colucci (66 yo)

4.7yrs
Tenure

Ms. Maria Gabriella Colucci is the Founder and Chairman of the Board of Directors and Chief Executive Officer at Arterra Bioscience S.p.A. and has been its President since 2022. She is Founder, President a...

Leadership Team

NamePositionTenureCompensationOwnership
Maria Colucci
Founder4.7yrsno data20.89%
€ 4.2m
Gualtiero Ioimo
Counselor5.3yrsno datano data
Giuseppe Ferrante
COO & Counselor2.7yrsno datano data
Vincenzo Fogliano
Chief Scientific Officerno datano datano data
4.7yrs
Average Tenure

Experienced Management: ARBS's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Maria Colucci
Founderno datano data20.89%
€ 4.2m
Gualtiero Ioimo
Counselorno datano datano data
Giuseppe Ferrante
COO & Counselor4.7yrsno datano data
Carlo Vasquez
Member of the Board of Statutory Auditorsno datano datano data
Paolo Gaeta
Chairman of the Board of Statutory Auditorsno datano datano data
Alberto Previtali
Counselor1.7yrsno datano data
Lucio Annunziato
Independent Counselor4.7yrsno datano data
Luca Tesio
Standing Statutory Auditorno datano datano data
4.7yrs
Average Tenure
66yo
Average Age

Experienced Board: ARBS's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 13:27
End of Day Share Price 2026/09/09 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arterra Bioscience S.p.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Valentina RomitelliValueTrack